The global drug delivery market has grown from an estimated $26bn in 2000 to approximately $60bn in 2006.
The market has witnessed rapid expansion due to patent expiration of blockbuster drugs, stringent FDA regulations, an increased focus on the expansion of products' life-cycle, cost-effective production of neoteric delivery vehicles, and the emergence of a range of delivery solutions and hybrid platforms.
1 Drug delivery advancements
2 Delivery of biopharmaceuticals
3 Delivery of therapeutic proteins and peptides
|Publication date:||Number of pages:||Price:|